Johnson & Johnson (NYSE:JNJ) is trading down 0.04% at 165.97 Safety concerns about Johnson & Johnson (NYSE:JNJ)’s COVID-19 vaccine along with overall flagging demand for vaccinations have slowed its U.S. rollout to a crawl, leaving close to half of the 21 million doses produced for the United States sitting...